featured
Ocriplasmin May Be Effective for Symptomatic Vitreomacular Adhesion
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Ophthalmology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Results of the 2-Year Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole (OASIS) Randomized Trial
Ophthalmology 2016 Aug 04;[EPub Ahead of Print], PU Dugel, M Tolentino, L Feiner, P Kozma, A LeroyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.